RSV, a common respiratory virus in infants and young children, is being studied as a safe, effective way to treat cancer. RSV already shows promise in anti-cancer trials overseas. US clinical trials could be on the horizon.
RSV, a common respiratory virus in infants and young children, is being studied as a safe, effective way to treat cancer. RSV already shows promise in anti-cancer trials overseas. US clinical trials could be on the horizon.